Scientific article
Open access

Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation

Published inMolecular psychiatry, vol. 27, no. 4, p. 1990-1999
Publication date2022-04
First online date2022-02-16

Alzheimer’s disease (AD) biomarkers represent several neurodegenerative processes, such as synaptic dysfunction, neuronal inflammation and injury, as well as amyloid pathology. We performed an exome-wide rare variant analysis of six AD biomarkers (β-amyloid, total/phosphorylated tau, NfL, YKL-40, and Neurogranin) to discover genes associated with these markers. Genetic and biomarker information was available for 480 participants from two studies: EMIF-AD and ADNI. We applied a principal component (PC) analysis to derive biomarkers combinations, which represent statistically independent biological processes. We then tested whether rare variants in 9576 protein-coding genes associate with these PCs using a Meta-SKAT test. We also tested whether the PCs are intermediary to gene effects on AD symptoms with a SMUT test. One PC loaded on NfL and YKL-40, indicators of neuronal injury and inflammation. Four genes were associated with this PC: IFFO1, DTNB, NLRC3, and SLC22A10. Mediation tests suggest, that these genes also affect dementia symptoms via inflammation/injury. We also observed an association between a PC loading on Neurogranin, a marker for synaptic functioning, with GABBR2 and CASZ1, but no mediation effects. The results suggest that rare variants in IFFO1, DTNB, NLRC3, and SLC22A10 heighten susceptibility to neuronal injury and inflammation, potentially by altering cytoskeleton structure and immune activity disinhibition, resulting in an elevated dementia risk. GABBR2 and CASZ1 were associated with synaptic functioning, but mediation analyses suggest that the effect of these two genes on synaptic functioning is not consequential for AD development.

  • Alzheimer Disease / diagnosis
  • Amyloid beta-Peptides / genetics
  • Biomarkers
  • Chitinase-3-Like Protein 1 / genetics
  • DNA-Binding Proteins
  • Dithionitrobenzoic Acid
  • Humans
  • Inflammation / genetics
  • Intercellular Signaling Peptides and Proteins
  • Neurogranin / genetics
  • Transcription Factors
  • Tau Proteins
Citation (ISO format)
NEUMANN, Alexander et al. Rare variants in <i>IFFO1</i>, <i>DTNB</i>, <i>NLRC3 </i>and <i>SLC22A10 </i>associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation. In: Molecular psychiatry, 2022, vol. 27, n° 4, p. 1990–1999. doi: 10.1038/s41380-022-01437-6
Main files (1)
Article (Published version)
Secondary files (3)
ISSN of the journal1359-4184

Technical informations

Creation11/16/2022 1:16:17 PM
First validation09/25/2023 10:44:58 AM
Update time09/25/2023 10:44:58 AM
Status update09/25/2023 10:44:58 AM
Last indexation02/01/2024 10:42:21 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack